|
GS174959: HP:0002540 Inability to walk
|
|
GS136869: triglyceride QTL 1 (Trigq1, Published QTL Chr 9)
|
|
GS36216: Neocortex Gene expression correlates of Novel environment locomotion (activity beam breaks) 30-45 min in the center in Females BXD
|
|
GS135716: dermititis 1 (Derm1, Published QTL Chr 9)
|
|
GS177044: HP:0001922 Vacuolated lymphocytes
|
|
GS171644: HP:0011842 Abnormality of skeletal morphology
|
|
GS175101: HP:0000280 Coarse facial features
|
|
GS135359: B.burgdorferi-associated arthritis 17 (Bbaa17, Published QTL Chr 9)
|
|
GS166257: MP:0005291 abnormal glucose tolerance
|
|
GS175130: HP:0000750 Delayed speech and language development
|
|
GS169830: MP:0005384 cellular phenotype
|
|
GS172294: HP:0001510 Growth delay
|
|
GS173392: HP:0003330 Abnormal bone structure
|
|
GS174134: HP:0002012 Abnormality of the abdominal organs
|
|
GS135548: CD4 T cell subset 4 (Cd4ts4, Published QTL Chr 9)
|
|
GS210701: GO:0015739 sialic acid transport
|
|
GS164564: MP:0003871 abnormal myelin sheath morphology
|
|
GS173407: HP:0002680 J-shaped sella turcica
|
|
GS174840: HP:0011358 Generalized hypopigmentation of hair
|
|
GS34654: Striatum Gene expression correlates of Novel environment locomotion (cm) 30-45 min in the periphery [Cocaine] in Females BXD
|
|
GS136266: modifier of mammary tumor progression 3 (Mmtp3, Published QTL Chr 9)
|
|
GS170968: HP:0000156 High-arched palate
|
|
GS176153: HP:0100820 Glomerulopathy
|
|
GS176385: HP:0001249 Intellectual disability
|
|
GS167898: MP:0009357 abnormal seizure response to inducing agent
|
|
GS176107: HP:0000929 Abnormality of the skull
|
|
GS181639: GO:0008028 monocarboxylic acid transmembrane transporter activity
|
|
GS173995: HP:0000508 Ptosis
|
|
GS181423: GO:0022891 substrate-specific transmembrane transporter activity
|
|
GS135884: femur geometry 8 (Fmgty8, Published QTL Chr 9)
|
|
GS195413: GO:0008509 anion transmembrane transporter activity
|
|
GS34740: Striatum Gene expression correlates of Novel environment rears 45-60 min in the periphery in Females & Males BXD
|
|
GS169585: MP:0001413 abnormal response to new environment
|
|
GS173408: HP:0002681 Deformed sella turcica
|
|
GS84213: differences in cocaine responsiveness (Published QTL, Chr 9)
|
|
GS172054: HP:0001507 Growth abnormality
|
|
GS177404: GO:0005737 cytoplasm
|
|
GS201251: GO:0044424 intracellular part
|
|
GS128598: Ethanol Induced Ataxia Chr#9
|
|
GS172060: HP:0001508 Failure to thrive
|
|
GS163837: MP:0008026 abnormal brain white matter morphology
|
|
GS170569: MP:0005404 abnormal axon morphology
|
|
GS192508: GO:0006811 ion transport
|
|
GS135351: Alzheimer's disease modifier 3 (Azdm3, Published QTL Chr 9)
|
|
GS170243: MP:0011085 complete postnatal lethality
|
|
GS183543: GO:0051179 localization
|
|
GS174338: HP:0002719 Recurrent infections
|
|
GS188752: GO:0044437 vacuolar part
|
|
GS175907: HP:0004349 Reduced bone mineral density
|
|
GS34663: Striatum Gene expression correlates of Novel environment locomotion (cm) 30-45 min in the periphery [Cocaine] in Males BXD
|
|
GS166660: MP:0001731 abnormal postnatal growth
|
|
GS195933: GO:0008514 organic anion transmembrane transporter activity
|
|
GS205500: GO:0071944 cell periphery
|
|
GS195044: GO:0005351 sugar:hydrogen symporter activity
|
|
GS36276: Neocortex Gene expression correlates of Novel environment locomotion (cm) 45-60 min in the center in Females BXD
|
|
GS136500: proteoglycan induced arthritis 5 (Pgia5, Published QTL Chr 9)
|
|
GS207982: GO:0005764 lysosome
|
|
GS209163: GO:0005773 vacuole
|
|
GS171436: HP:0000077 Abnormality of the kidney
|
|
GS175116: HP:0000577 Exotropia
|
|
GS163824: MP:0001259 abnormal body weight
|
|
GS190516: GO:0015293 symporter activity
|
|
GS136348: nociceptive sensitivity inflammatory QTL 1 (Nociq1, Published QTL Chr 9)
|
|
GS175909: HP:0004348 Abnormality of bone mineral density
|
|
GS207409: GO:0015291 secondary active transmembrane transporter activity
|
|
GS173355: HP:0002205 Recurrent respiratory infections
|
|
GS84221: differences in cocaine responsiveness (Published QTL, Chr 9)
|
|
GS175601: HP:0002086 Abnormality of the respiratory system
|
|
GS170933: HP:0001288 Gait disturbance
|
|
GS178284: GO:0031090 organelle membrane
|
|
GS35327: Neocortex Gene expression correlates of Open Field rears 15-30 min post saline in Females & Males BXD
|
|
GS84223: differences in cocaine responsiveness (Published QTL, Chr 9)
|
|
GS176203: HP:0000478 Abnormality of the eye
|
|
GS207614: GO:0016023 cytoplasmic membrane-bounded vesicle
|
|
GS172185: HP:0002977 Aplasia/Hypoplasia involving the central nervous system
|
|
GS192671: GO:0055085 transmembrane transport
|
|
GS195226: GO:0015075 ion transmembrane transporter activity
|
|
GS176591: HP:0001276 Hypertonia
|
|
GS135536: caffeine metabolism QTL 3 (Cafq3, Published QTL Chr 9)
|
|
GS173449: HP:0002683 Abnormality of the calvaria
|
|
GS174756: HP:0011947 Respiratory tract infection
|
|
GS179401: GO:0005215 transporter activity
|
|
GS210107: GO:1901476 carbohydrate transporter activity
|
|
GS136121: life span 1 (Lifespan1, Published QTL Chr 9)
|
|
GS186744: GO:0043226 organelle
|
|
GS198782: GO:0044459 plasma membrane part
|
|
GS182835: GO:0005622 intracellular
|
|
GS34765: Striatum Gene expression correlates of Novel environment vertical activity counts minutes 45-60 in Females & Males BXD
|
|
GS169075: MP:0002078 abnormal glucose homeostasis
|
|
GS34467: Striatum Gene expression correlates of Novel environment locomotion (activity beam breaks) 15-30 min in the periphery [Cocaine] in Females
|
|
GS83993: cocaine related behavior 9 (Cocrb9, Published QTL, Chr 9)
|
|
GS170999: HP:0000082 Abnormality of renal physiology
|
|
GS84217: differences in cocaine responsiveness (Published QTL, Chr 9)
|
|
GS184448: GO:0044425 membrane part
|
|
GS175896: HP:0000938 Osteopenia
|
|
GS200341: GO:0051179 localization
|
|
GS174994: HP:0002059 Cerebral atrophy
|
|
GS171600: HP:0000168 Abnormality of the gingiva
|
|
GS135822: ethanol conditioned taste aversion 8 (Etohcta8, Published QTL Chr 9)
|
|
GS175528: HP:0000007 Autosomal recessive inheritance
|
|
GS171815: HP:0001574 Abnormality of the integument
|
|
GS170791: HP:0010978 Abnormality of immune system physiology
|
|
GS175526: HP:0000005 Mode of inheritance
|
|
GS36289: Striatum Gene expression correlates of Open Field InovelTOTAL locomotion (activity beam breaks) in the center in BXD Females
|
|
GS207616: GO:0016020 membrane
|
|
GS171647: HP:0011844 Abnormal appendicular skeleton morphology
|
|
GS173403: HP:0002684 Thickened calvaria
|
|
GS164264: MP:0002082 postnatal lethality
|
|
GS172415: HP:0002240 Hepatomegaly
|
|
GS205321: GO:0031410 cytoplasmic vesicle
|
|
GS163601: MP:0002089 abnormal postnatal growth/weight/body size
|
|
GS179166: GO:0008514 organic anion transmembrane transporter activity
|
|
GS169229: MP:0001407 short stride length
|
|
GS163662: MP:0005277 abnormal brainstem morphology
|
|
GS208177: GO:0051119 sugar transmembrane transporter activity
|
|
GS168606: MP:0000778 abnormal nervous system tract morphology
|
|
GS84222: differences in cocaine responsiveness (Published QTL, Chr 9)
|
|
GS165527: MP:0005378 growth/size phenotype
|
|
GS36863: Cerebellum Gene expression correlates of Percentage of entries into open arms of plus maze in Females BXD
|
|
GS175529: HP:0000001 All
|
|
GS200204: GO:0015849 organic acid transport
|
|
GS171252: HP:0003819 Death in childhood
|
|
GS35342: Neocortex Gene expression correlates of Open Field Rears 45-60 min post saline in Females BXD
|
|
GS198238: GO:0046943 carboxylic acid transmembrane transporter activity
|
|
GS34537: Striatum Gene expression correlates of Novel environment locomotion (activity beam breaks) 45-60 min in the periphery in BXD Males
|
|
GS186740: GO:0043229 intracellular organelle
|
|
GS34737: Neocortex Gene expression correlates of Novel environment rears 30-45 min in the periphery in Males BXD
|
|
GS176568: HP:0000486 Strabismus
|
|
GS208012: GO:0044464 cell part
|
|
GS87380: Table S1: Additional data file 1 is a table listing the results of two-way ANOVA (FDR < 1%). (Whole Table) [DRG]
|
|
GS201252: GO:0044425 membrane part
|
|
GS175407: HP:0002072 Chorea
|
|
GS136453: postnatal body weight growth 15 (Pbwg15, Published QTL Chr 9)
|
|
GS34635: Striatum Gene expression correlates of Novel environment locomotion (cm) 30-45 min in the periphery in BXD Females
|
|
GS135288: alcohol response 4 (Alcrsp4, Published QTL Chr 9)
|
|
GS168746: MP:0002199 abnormal brain commissure morphology
|
|
GS176234: HP:0002305 Athetosis
|
|
GS34673: Hippocampus Gene expression correlates of Novel environment locomotion (cm) 45-60 min in the periphery in Females BXD
|
|
GS34415: Neocortex Gene expression correlates of Novel environment rears 45-60 min in the center in Females & Males BXD
|
|
GS176730: HP:0000100 Nephrotic syndrome
|
|
GS136911: vertebral morphology and mechanical traits 16 (Vmmt16, Published QTL Chr 9)
|
|
GS176101: HP:0000924 Abnormality of the skeletal system
|
|
GS184220: GO:0071702 organic substance transport
|
|
GS170841: HP:0001107 Ocular albinism
|
|
GS176771: HP:0001000 Abnormality of skin pigmentation
|
|
GS172154: HP:0002679 Abnormality of the sella turcica
|
|
GS176801: HP:0001263 Global developmental delay
|
|
GS173686: HP:0001640 Cardiomegaly
|
|
GS174385: HP:0002088 Abnormality of the lung
|
|
GS174500: HP:0000707 Abnormality of the nervous system
|
|
GS171998: HP:0001939 Abnormality of metabolism/homeostasis
|
|
GS36226: Neocortex Gene expression correlates of Novel environment locomotion (activity beam breaks) 45-60 min in the center in Females & Males BXD
|
|
GS167020: MP:0003956 abnormal body size
|
|
GS164263: MP:0002083 premature death
|
|
GS181425: GO:0022892 substrate-specific transporter activity
|
|
GS174059: HP:0002908 Conjugated hyperbilirubinemia
|
|
GS182834: GO:0005623 cell
|
|
GS168021: MP:0000745 tremors
|
|
GS176167: HP:0001257 Spasticity
|
|
GS199201: GO:0031224 intrinsic to membrane
|
|
GS173083: HP:0000492 Abnormality of the eyelid
|
|
GS35345: Striatum Gene expression correlates of Open Field Rears 45-60 min post saline in Males BXD
|
|
GS136794: taste bitterness sensitivity 11 (Taste11, Published QTL Chr 9)
|
|
GS167884: MP:0009358 environmentally induced seizures
|
|
GS174067: HP:0002904 Hyperbilirubinemia
|
|
GS136277: multigenic obesity QTL 8 (Mobq8, Published QTL Chr 9)
|
|
GS174914: HP:0003011 Abnormality of the musculature
|
|
GS178576: GO:1901505 carbohydrate derivative transporter activity
|
|
GS185714: GO:0015718 monocarboxylic acid transport
|
|
GS199635: GO:0005622 intracellular
|
|
GS171461: HP:0011121 Abnormality of skin morphology
|
|
GS34528: Hippocampus Gene expression correlates of Novel environment locomotion (activity beam breaks) 45-60 min in the periphery in Females BXD
|
|
GS168012: MP:0010832 lethality during fetal growth through weaning
|
|
GS164676: MP:0004267 abnormal optic tract morphology
|
|
GS34556: Striatum Gene expression correlates of Novel environment locomotion (activity beam breaks) 45-60 min in the periphery [Cocaine] in Males BXD
|
|
GS209550: GO:0031982 vesicle
|
|
GS174810: HP:0001635 Congestive heart failure
|
|
GS198427: GO:0008028 monocarboxylic acid transmembrane transporter activity
|
|
GS136756: susceptibility to Salmonella typhimurium antigens 7 (Ssta7, Published QTL Chr 9)
|
|
GS167919: MP:0000954 decreased oligodendrocyte progenitor number
|
|
GS174075: HP:0009121 Abnormal axial skeleton morphology
|
|
GS196941: GO:0008150 biological_process
|
|
GS168838: MP:0003107 abnormal response to novelty
|
|
GS198212: GO:0022891 substrate-specific transmembrane transporter activity
|
|
GS34595: Striatum Gene expression correlates of Novel environment distance (cm) travelled min 15-30 in BXD Females
|
|
GS207410: GO:0015293 symporter activity
|
|
GS199634: GO:0005623 cell
|
|
GS164136: MP:0000001 mammalian phenotype
|
|
GS135710: diabetes susceptibility QTL 8 (Dbsq8, Published QTL Chr 9)
|
|
GS169386: MP:0002063 abnormal learning/memory/conditioning
|
|
GS84224: ethanol withdrawal (Published QTL, Chr 9)
|
|
GS197314: GO:0000323 lytic vacuole
|
|
GS197009: GO:0005886 plasma membrane
|
|
GS175539: HP:0007256 Abnormality of pyramidal motor function
|
|
GS209735: GO:0008324 cation transmembrane transporter activity
|
|
GS136547: periosteal circumference 6 (Pstc6, Published QTL Chr 9)
|
|
GS201256: GO:0044422 organelle part
|
|
GS136768: streptozotocin induced diabetes susceptibility 2 (Stzid2, Published QTL Chr 9)
|
|
GS135253: adiposity 5 (Adip5, Published QTL Chr 9)
|
|
GS203887: GO:1901264 carbohydrate derivative transport
|
|
GS84227: METH responses for body temperature (Published QTL, Chr 9)
|
|
GS173743: HP:0001999 Abnormal facial shape
|
|
GS176613: HP:0000271 Abnormality of the face
|
|
GS177055: HP:0005599 Hypopigmentation of hair
|
|
GS135300: alcohol preference QTL 3 (Alpq3, Published QTL Chr 9)
|
|
GS84216: alcohol consumption (Published QTL, Chr 9)
|
|
GS36281: Neocortex Gene expression correlates of Novel environment locomotion (cm) 45-60 min in the center in Males BXD
|
|
GS128581: BECs at LORR Recovery Chr# 9
|
|
GS173147: HP:0011283 Abnormality of the metencephalon
|
|
GS84215: differences in cocaine responsiveness (Published QTL, Chr 9)
|
|
GS34701: Striatum Gene expression correlates of Novel environment locomotion (cm) 45-60 min in the periphery [Cocaine] in Males BXD
|
|
GS209613: GO:0055085 transmembrane transport
|
|
GS175016: HP:0001626 Abnormality of the cardiovascular system
|
|
GS170825: HP:0002167 Neurological speech impairment
|
|
GS175990: HP:0000463 Anteverted nares
|
|
GS179592: GO:0006820 anion transport
|
|
GS135588: P. chabaudi malaria resistance QTL 1 (Char1, Published QTL Chr 9)
|
|
GS169362: MP:0000920 abnormal myelination
|
|
GS193059: GO:0044446 intracellular organelle part
|
|
GS176172: HP:0001251 Ataxia
|
|
GS189208: GO:0005765 lysosomal membrane
|
|
GS135371: B.burgdorferi-associated arthritis 9 (Bbaa9, Published QTL Chr 9)
|
|
GS209564: GO:0043231 intracellular membrane-bounded organelle
|
|
GS207379: GO:0005402 cation:sugar symporter activity
|
|
GS171274: HP:0100543 Cognitive impairment
|
|
GS173667: HP:0010318 Aplasia/Hypoplasia of the abdominal wall musculature
|
|
GS175805: HP:0003271 Visceromegaly
|
|
GS209586: GO:0022804 active transmembrane transporter activity
|
|
GS175981: HP:0000163 Abnormality of the oral cavity
|
|
GS209452: GO:0006810 transport
|
|
GS34634: Striatum Gene expression correlates of Novel environment locomotion (cm) 30-45 min in the periphery in Females BXD
|
|
GS175015: HP:0001627 Abnormality of the heart
|
|
GS169363: MP:0000921 demyelination
|
|
GS175096: HP:0000286 Epicanthus
|
|
GS165260: MP:0001392 abnormal locomotor behavior
|
|
GS167759: MP:0000787 abnormal telencephalon morphology
|
|
GS168843: MP:0005293 impaired glucose tolerance
|
|
GS176186: HP:0000079 Abnormality of the urinary system
|
|
GS163834: MP:0008025 brain vacuoles
|
|
GS172620: HP:0000657 Oculomotor apraxia
|
|
GS176900: HP:0000218 High palate
|
|
GS163971: MP:0002092 abnormal eye morphology
|
|
GS127240: Acetaminophen interacting genes (MeSH:D000082) in CTD
|
|
GS178656: GO:0008509 anion transmembrane transporter activity
|
|
GS194459: GO:0051234 establishment of localization
|
|
GS188465: GO:0031410 cytoplasmic vesicle
|
|
GS136737: submucosal gland distribution 1 (Smgd1, Published QTL Chr 9)
|
|
GS165538: MP:0005377 hearing/vestibular/ear phenotype
|
|
GS196355: GO:0006820 anion transport
|
|
GS136912: vertebral morphology and mechanical traits 17 (Vmmt17, Published QTL Chr 9)
|
|
GS165397: MP:0001265 decreased body size
|
|
GS168218: MP:0001963 abnormal hearing physiology
|
|
GS175233: HP:0002286 Fair hair
|
|
GS171789: HP:0001392 Abnormality of the liver
|
|
GS169095: MP:0004924 abnormal behavior
|
|
GS136038: inflammatory bowel disease QTL 1 (Ibdq1, Published QTL Chr 9)
|
|
GS164570: MP:0003878 abnormal ear physiology
|
|
GS34486: Striatum Gene expression correlates of Novel environment locomotion (activity beam breaks) 30-45 min in the periphery in Females BXD
|
|
GS175565: HP:0003025 Irregular metaphyses
|
|
GS163101: MP:0008540 abnormal cerebrum morphology
|
|
GS170965: HP:0000153 Abnormality of the mouth
|
|
GS171204: HP:0011314 Abnormality of long bone morphology
|
|
GS198403: GO:0015136 sialic acid transmembrane transporter activity
|
|
GS203594: GO:0043226 organelle
|
|
GS84214: differences in cocaine responsiveness (Published QTL, CHr 9)
|
|
GS136666: skin tumor susceptibility 6 (Skts6, Published QTL Chr 9)
|
|
GS210002: GO:0044444 cytoplasmic part
|
|
GS171168: HP:0000234 Abnormality of the head
|
|
GS35896: Cerebellum Gene expression correlates of Number of entries into open arms of plus maze in Females BXD
|
|
GS171908: HP:0004298 Abnormality of the abdominal wall
|
|
GS170567: MP:0003997 tonic-clonic seizures
|
|
GS135343: atherosclerosis 29 (Ath29, Published QTL Chr 9)
|
|
GS181613: GO:0015136 sialic acid transmembrane transporter activity
|
|
GS165537: MP:0005376 homeostasis/metabolism phenotype
|
|
GS135911: G protein deficiency-induced colitis 3 (Gpdc3, Published QTL Chr 9)
|
|
GS174331: HP:0002715 Abnormality of the immune system
|
|
GS167622: MP:0002152 abnormal brain morphology
|
|
GS167585: MP:0001417 decreased exploration in new environment
|
|
GS175668: HP:0007369 Atrophy/Degeneration affecting the cerebrum
|
|
GS168958: MP:0003492 abnormal involuntary movement
|
|
GS203593: GO:0043227 membrane-bounded organelle
|
|
GS164742: MP:0001732 postnatal growth retardation
|
|
GS171178: HP:0000238 Hydrocephalus
|
|
GS182404: GO:0031224 intrinsic to membrane
|
|
GS210000: GO:0044446 intracellular organelle part
|
|
GS35332: Neocortex Gene expression correlates of Open Field Rears 30-45 min post saline in Females BXD
|
|
GS174131: HP:0002011 Abnormality of the central nervous system
|
|
GS169658: MP:0002572 abnormal emotion/affect behavior
|
|
GS194087: GO:0003674 molecular_function
|
|
GS84228: alcohol response 4 (Alcrp4, Published QTL, Chr 9)
|
|
GS171424: HP:0002814 Abnormality of the lower limb
|
|
GS169062: MP:0000913 abnormal brain development
|
|
GS175692: HP:0200042 Skin ulcer
|
|
GS177356: GO:0003674 molecular_function
|
|
GS207615: GO:0016021 integral to membrane
|
|
GS203590: GO:0043229 intracellular organelle
|
|
GS36261: Neocortex Gene expression correlates of Novel environment locomotion (cm) 30-45 min in the center in Females BXD
|
|
GS176245: HP:0011443 Abnormality of coordination
|
|
GS190653: GO:0005342 organic acid transmembrane transporter activity
|
|
GS170131: MP:0008415 abnormal neurite morphology
|
|
GS175119: HP:0001881 Abnormality of leukocytes
|
|
GS35109: Neocortex Gene expression correlates of Open Field TOTAL rears post saline in Females BXD
|
|
GS172272: HP:0001197 Abnormality of prenatal development or birth
|
|
GS175020: HP:0001622 Premature birth
|
|
GS164446: MP:0005195 abnormal posterior eye segment morphology
|
|
GS173223: HP:0007730 Iris hypopigmentation
|
|
GS34548: Hippocampus Gene expression correlates of Novel environment locomotion (activity beam breaks) 45-60 min in the periphery [Cocaine] in Females BXD
|
|
GS207551: GO:0005342 organic acid transmembrane transporter activity
|
|
GS87137: Table S2: List of probe-sets of genes differentially expressed among the four inbred strains of mice. Gene Ranks [DRG]
provisional
|
|
GS171832: HP:0000118 Phenotypic abnormality
|
|
GS178474: GO:0015075 ion transmembrane transporter activity
|
|
GS197610: GO:0022857 transmembrane transporter activity
|
|
GS136084: keratinocyte stem cell locus 1 (Ksc1, Published QTL Chr 9)
|
|
GS136145: lithogenic gene 5 (Lith5, Published QTL Chr 9)
|
|
GS183410: GO:0015849 organic acid transport
|
|
GS135321: accelerator of polyoma-induced mammary tumors 2 (Apmt2, Published QTL Chr 9)
|
|
GS167753: MP:0000780 abnormal corpus callosum morphology
|
|
GS168890: MP:0000746 weakness
|
|
GS135429: bone mineral density 10 (Bmd10, Published QTL Chr 9)
|
|
GS192509: GO:0006810 transport
|
|
GS34545: Striatum Gene expression correlates of Novel environment locomotion (activity beam breaks) 45-60 min in the periphery in BXD Females
|
|
GS169531: MP:0005391 vision/eye phenotype
|
|
GS175537: HP:0011277 Abnormality of the urinary system physiology
|
|
GS36158: Neocortex Gene expression correlates of Locomotor response of 10 mg/kg MDMA injected on Day 2 in Females BXD
|
|
GS172118: HP:0004332 Abnormality of lymphocytes
|
|
GS36271: Neocortex Gene expression correlates of Novel environment locomotion (cm) 45-60 min in the center in Females & Males BXD
|
|
GS136764: soft tissue heal 8 (Stheal8, Published QTL Chr 9)
|
|
GS176560: HP:0001010 Hypopigmentation of the skin
|
|
GS197008: GO:0005887 integral to plasma membrane
|
|
GS168956: MP:0003491 abnormal voluntary movement
|
|
GS172470: HP:0001743 Abnormality of the spleen
|
|
GS190714: GO:0016020 membrane
|
|
GS176477: HP:0002118 Abnormality of the cerebral ventricles
|
|
GS34644: Striatum Gene expression correlates of Novel environment locomotion (cm) 30-45 min in the periphery in BXD Males
|
|
GS34615: Striatum Gene expression correlates of Novel environment distance (cm) travelled min 15-30 [Cocaine] in Females BXD
|
|
GS136194: learning contextual 3 (Lrnx3, Published QTL Chr 9)
|
|
GS171139: HP:0005288 Abnormality of the nares
|
|
GS175098: HP:0000284 Abnormality of the ocular region
|
|
GS34766: Neocortex Gene expression correlates of Novel environment vertical activity counts minutes 45-60 in Females & Males BXD
|
|
GS173787: HP:0002813 Abnormality of limb bone morphology
|
|
GS196398: GO:0015144 carbohydrate transmembrane transporter activity
|
|
GS176171: HP:0001250 Seizures
|
|
GS195214: GO:0009987 cellular process
|
|
GS163934: MP:0001764 abnormal homeostasis
|
|
GS184452: GO:0044422 organelle part
|
|
GS195328: GO:1901505 carbohydrate derivative transporter activity
|
|
GS165525: MP:0010768 mortality/aging
|
|
GS175673: HP:0100022 Abnormality of movement
|
|
GS196168: GO:0005215 transporter activity
|
|
GS34487: Striatum Gene expression correlates of Novel environment locomotion (activity beam breaks) 30-45 min in the periphery in BXD Females
|
|
GS34643: Striatum Gene expression correlates of Novel environment locomotion (cm) 30-45 min in the periphery in Males BXD
|
|
GS172699: HP:0002652 Skeletal dysplasia
|
|
GS180817: GO:0022857 transmembrane transporter activity
|
|
GS201025: GO:0071702 organic substance transport
|
|
GS36314: Striatum Gene expression correlates of Open Field Inovel TOTAL rears in the center in BXD Females & Males
|
|
GS135422: bleomycin-induced pulmonary fibrosis 3 (Blmpf3, Published QTL Chr 9)
|
|
GS169225: MP:0000358 abnormal cell morphology
|
|
GS174917: HP:0000765 Abnormality of the thorax
|
|
GS174335: HP:0001871 Abnormality of blood and blood-forming tissues
|
|
GS36256: Neocortex Gene expression correlates of Novel environment locomotion (cm) 30-45 min in the center in Females & Males BXD
|
|
GS86906: Table S1: Additional data file 1 is a table listing the results of two-way ANOVA (FDR < 1%). Lists of probe sets and gene names altered by strain (3457). [DRG]
provisional
|
|
GS176040: HP:0011032 Abnormality of fluid regulation
|
|
GS180319: GO:0046942 carboxylic acid transport
|
|
GS175169: HP:0001317 Abnormality of the cerebellum
|
|
GS34693: Hippocampus Gene expression correlates of Novel environment locomotion (cm) 45-60 min in the periphery [Cocaine] in Females BXD
|
|
GS202545: GO:0015718 monocarboxylic acid transport
|
|
GS165524: MP:0010769 abnormal survival
|
|
GS34762: Neocortex Gene expression correlates of Novel environment vertical activity counts min 30-45 in Females & Males BXD
|
|
GS34446: Striatum Gene expression correlates of Novel environment locomotion (activity beam breaks) 15-30 min in the periphery in Females BXD
|
|
GS172365: HP:0003110 Abnormality of urine homeostasis
|
|
GS84225: METH responses for home cage activity (Published QTL, Chr 9)
|
|
GS34803: Striatum Gene expression correlates of Open Field Inovel TOTAL locomotion ( cm in 1 hr) in the center in BXD Females
|
|
GS164539: MP:0003360 abnormal depression-related behavior
|
|
GS165243: MP:0010770 preweaning lethality
|
|
GS169393: MP:0002064 seizures
|
|
GS209175: GO:0005774 vacuolar membrane
|
|
GS176141: HP:0001789 Hydrops fetalis
|
|
GS172362: HP:0004325 Decreased body weight
|
|
GS174706: HP:0000553 Abnormality of the uvea
|
|
GS172353: HP:0004329 Abnormality of the posterior segment of the eye
|
|
GS34730: Striatum Gene expression correlates of Novel environment rears 30-45 min in the periphery in Females BXD
|
|
GS198214: GO:0022892 substrate-specific transporter activity
|
|
GS34760: Striatum Gene expression correlates of Novel environment vertical activity counts min 30-45 in Females & Males BXD
|
|
GS174453: HP:0001438 Abnormality of the abdomen
|
|
GS180164: GO:0008150 biological_process
|
|
GS34507: Striatum Gene expression correlates of Novel environment locomotion (activity beam breaks) 30-45 min in the periphery [Cocaine] in Females BXD
|
|
GS34681: Striatum Gene expression correlates of Novel environment locomotion (cm) 45-60 min in the periphery in Males BXD
|
|
GS176333: HP:0007319 Morphological abnormality of the central nervous system
|
|
GS209555: GO:0031988 membrane-bounded vesicle
|
|
GS206073: GO:0005765 lysosomal membrane
|
|
GS171833: HP:0000119 Abnormality of the genitourinary system
|
|
GS176756: HP:0011420 Death
|
|
GS135374: body length 4 (Bdln4, Published QTL Chr 9)
|
|
GS129159: neonatal growth QTL 1 (Neogq1 Published QTL Chr 9)
|
|
GS173476: HP:0002311 Incoordination
|
|
GS177721: GO:0051234 establishment of localization
|
|
GS136044: insulin dependent diabetes susceptibility 2 (Idd2, Published QTL Chr 9)
|
|
GS165465: MP:0003633 abnormal nervous system physiology
|
|
GS171258: HP:0011138 Abnormality of skin adnexa
|
|
GS176924: HP:0000212 Gingival overgrowth
|
|
GS125506: Valproic Acid interacting genes (MeSH:D014635) in CTD
|
|
GS174646: HP:0000951 Abnormality of the skin
|
|
GS164220: MP:0002882 abnormal neuron morphology
|
|
GS34529: Hippocampus Gene expression correlates of Novel environment locomotion (activity beam breaks) 45-60 min in the periphery in BXD Females
|
|
GS34682: Striatum Gene expression correlates of Novel environment locomotion (cm) 45-60 min in the periphery in BXD Males
|
|
GS170738: MP:0001056 abnormal cranial nerve morphology
|
|
GS172666: HP:0011804 Abnormality of muscle physiology
|
|
GS188641: GO:0071944 cell periphery
|
|
GS175107: HP:0003808 Abnormal muscle tone
|
|
GS164320: MP:0003861 abnormal nervous system development
|
|
GS178461: GO:0009987 cellular process
|
|
GS193061: GO:0044444 cytoplasmic part
|
|
GS172015: HP:0000969 Edema
|
|
GS192624: GO:0043231 intracellular membrane-bounded organelle
|
|
GS167630: MP:0000947 convulsive seizures
|
|
GS186743: GO:0043227 membrane-bounded organelle
|
|
GS173113: HP:0002186 Apraxia
|
|
GS174002: HP:0000189 Narrow palate
|
|
GS174488: HP:0000525 Abnormality of the iris
|
|
GS136674: skull morphology 13 (Skull13, Published QTL Chr 9)
|
|
GS193268: GO:0005575 cellular_component
|
|
GS136324: non-heme iron levels 5 (Nhil5, Published QTL Chr 9)
|
|
GS192242: GO:0005774 vacuolar membrane
|
|
GS36316: Neocortex Gene expression correlates of Open Field Inovel TOTAL rears in the center in BXD Females & Males
|
|
GS175815: HP:0011025 Abnormality of cardiovascular system physiology
|
|
GS171902: HP:0010987 Abnormality of cellular immune system
|
|
GS176817: HP:0011446 Abnormality of higher mental function
|
|
GS190713: GO:0016021 integral to membrane
|
|
GS172032: HP:0000366 Abnormality of the nose
|
|
GS86420: Table S4: Cocaine Regulation of Dimethyl-K9 / K27 H3. [DRG]
provisional
|
|
GS34536: Striatum Gene expression correlates of Novel environment locomotion (activity beam breaks) 45-60 min in the periphery in Males BXD
|
|
GS165466: MP:0003632 abnormal nervous system morphology
|
|
GS172471: HP:0001744 Splenomegaly
|
|
GS172737: HP:0010991 Abnormality of the abdominal musculature
|
|
GS171209: HP:0000093 Proteinuria
|
|
GS169228: MP:0001406 abnormal gait
|
|
GS170964: HP:0000152 Abnormality of head and neck
|
|
GS163049: MP:0002573 behavioral despair
|
|
GS171211: HP:0000091 Abnormality of the renal tubule
|
|
GS164681: MP:0004262 abnormal physical strength
|
|
GS191106: GO:0044464 cell part
|
|
GS173290: HP:0011354 Generalized abnormality of skin
|
|
GS176364: HP:0008034 Abnormal iris pigmentation
|
|
GS176241: HP:0010935 Abnormality of the upper urinary tract
|
|
GS163226: MP:0003312 abnormal locomotor coordination
|
|
GS174187: HP:0001595 Abnormality of the hair
|
|
GS171277: HP:0100547 Abnormality of the forebrain
|
|
GS34742: Neocortex Gene expression correlates of Novel environment rears 45-60 min in the periphery in Females & Males BXD
|
|
GS173146: HP:0011282 Abnormality of the hindbrain
|
|
GS192230: GO:0005773 vacuole
|
|
GS136431: pulmonary adenoma susceptibility 4 (Pas4, Published QTL Chr 9)
|
|
GS172134: HP:0000639 Nystagmus
|
|
GS171999: HP:0001760 Abnormality of the foot
|
|
GS175220: HP:0009887 Abnormality of hair pigmentation
|
|
GS135768: experimental allergic encephalomyelitis susceptibility 9 (Eae9, Published QTL Chr 9)
|
|
GS181448: GO:0046943 carboxylic acid transmembrane transporter activity
|
|
GS164059: MP:0006325 impaired hearing
|
|
GS172360: HP:0004323 Abnormality of body weight
|
|
GS207406: GO:0015294 solute:cation symporter activity
|
|
GS192615: GO:0031988 membrane-bounded vesicle
|
|
GS135474: brachyury modifier 1 (Brm1, Published QTL Chr 9)
|
|
GS136857: tri-nitrobenzene sulfonic acid susceptible 1 (Tnbs1, Published QTL Chr 9)
|
|
GS84218: differences in cocaine responsiveness (Published QTL, Chr 9)
|
|
GS169828: MP:0005386 behavior/neurological phenotype
|
|
GS191074: GO:0005764 lysosome
|
|
GS176844: HP:0000429 Abnormality of the nasal alae
|
|
GS171253: HP:0002817 Abnormality of the upper limb
|
|
GS176672: HP:0000980 Pallor
|
|
GS166244: MP:0002752 abnormal somatic nervous system morphology
|
|
GS167755: MP:0000783 abnormal forebrain morphology
|
|
GS84220: morphine antinociception (Published QTL, Chr 9)
|
|
GS194133: GO:0005737 cytoplasm
|
|
GS176231: HP:0010938 Abnormality of the external nose
|
|
GS135863: femur breaking strength 6 (Fembrs6, Published QTL Chr 9)
|
|
GS174217: HP:0005105 Abnormal nasal morphology
|
|
GS176642: HP:0011355 Localized skin lesion
|
|
GS175525: HP:0000004 Onset and clinical course
|
|
GS174764: HP:0007367 Atrophy/Degeneration affecting the central nervous system
|
|
GS199199: GO:0031226 intrinsic to plasma membrane
|
|
GS190712: GO:0016023 cytoplasmic membrane-bounded vesicle
|
|
GS180521: GO:0000323 lytic vacuole
|
|
GS163803: MP:0003631 nervous system phenotype
|
|
GS173079: HP:0000496 Abnormality of eye movement
|
|
GS165386: MP:0001262 decreased body weight
|
|
GS172857: HP:0004305 Involuntary movements
|
|
GS192646: GO:0022804 active transmembrane transporter activity
|
|
GS169391: MP:0002066 abnormal motor capabilities/coordination/movement
|
|
GS207405: GO:0015295 solute:hydrogen symporter activity
|
|
GS136007: haloperidol-induced catalepsy 1 (Hpic1, Published QTL Chr 9)
|
|
GS177031: HP:0011442 Abnormality of central motor function
|
|
GS172354: HP:0004328 Abnormality of the anterior segment of the eye
|
|
GS174851: HP:0000944 Abnormality of the metaphyses
|
|
GS166899: MP:0001330 abnormal optic nerve morphology
|
|
GS174836: HP:0001098 Abnormality of the fundus
|
|
GS136118: body length 5 (Lgth5, Published QTL Chr 9)
|
|
GS192609: GO:0031982 vesicle
|
|
GS185720: GO:0015711 organic anion transport
|
|
GS180229: GO:0005886 plasma membrane
|
|
GS169004: MP:0008219 abnormal dorsal telencephalic commissure morphology
|
|
GS202551: GO:0015711 organic anion transport
|
|
GS34447: Striatum Gene expression correlates of Novel environment locomotion (activity beam breaks) 15-30 min in the periphery in Females
|
|
GS136940: vertebral trabecular bone trait 8 (Vtbt8, Published QTL Chr 9)
|
|
GS176170: HP:0001252 Muscular hypotonia
|
|
GS171175: HP:0001541 Ascites
|
|
GS84226: differences in cocaine responsiveness (Published QTL, Chr 9)
|
|
GS174948: HP:0100763 Abnormality of the lymphatic system
|
|
GS34594: Striatum Gene expression correlates of Novel environment distance (cm) travelled min 15-30 in Females BXD
|
|
GS176803: HP:0001260 Dysarthria
|
|
GS184447: GO:0044424 intracellular part
|
|
GS193754: GO:0015739 sialic acid transport
|
|
GS171394: HP:0000174 Abnormality of the palate
|
|
GS34674: Hippocampus Gene expression correlates of Novel environment locomotion (cm) 45-60 min in the periphery in BXD Females
|
|
GS136710: susceptibility to lung cancer 11 (Sluc11, Published QTL Chr 9)
|
|
GS187024: GO:1901264 carbohydrate derivative transport
|
|
GS136840: T lymphocyte fraction (Tlf, Published QTL Chr 9)
|
|
GS84219: cocaine related behavior (Published QTL, Chr 9)
|
|
GS175191: HP:0002060 Abnormality of the cerebrum
|
|
GS195036: GO:0031090 organelle membrane
|
|
GS190515: GO:0015291 secondary active transmembrane transporter activity
|
|
GS171448: HP:0000606 Abnormality of the periorbital region
|
|
GS210212: GO:0005575 cellular_component
|
|
GS197101: GO:0046942 carboxylic acid transport
|
|
GS209451: GO:0006811 ion transport
|
|
GS205611: GO:0044437 vacuolar part
|
|
GS136140: lithogenic gene 20 (Lith20, Published QTL Chr 9)
|